Titre : Hémoglobinurie

Hémoglobinurie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Likelihood Functions
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hémoglobinurie : Questions médicales les plus fréquentes", "headline": "Hémoglobinurie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hémoglobinurie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-28", "dateModified": "2025-02-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hémoglobinurie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéinurie", "url": "https://questionsmedicales.fr/mesh/D011507", "about": { "@type": "MedicalCondition", "name": "Protéinurie", "code": { "@type": "MedicalCode", "code": "D011507", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.942.750" } } }, "about": { "@type": "MedicalCondition", "name": "Hémoglobinurie", "alternateName": "Hemoglobinuria", "code": { "@type": "MedicalCode", "code": "D006456", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hubert Schrezenmeier", "url": "https://questionsmedicales.fr/author/Hubert%20Schrezenmeier", "affiliation": { "@type": "Organization", "name": "Institute of Transfusion Medicine, University of Ulm, Ulm, Germany." } }, { "@type": "Person", "name": "Austin G Kulasekararaj", "url": "https://questionsmedicales.fr/author/Austin%20G%20Kulasekararaj", "affiliation": { "@type": "Organization", "name": "From the Hematology and Transplant Unit, French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Saint-Louis Hospital (R.P.L., F.S.F.), and Université de Paris (R.P.L.), Paris, Centre Hospitalier Universitaire (CHU) de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (S.T.), and CHU Lille, Université de Lille, Lille (L.T.) - all in France; the Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen (A.R., F.A.), the Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, University Hospital RWTH Aachen, and the Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Aachen (J.P.), the University of Ulm, the Institute of Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen, and University Hospital Ulm, Ulm (H.S., B. Höchsmann), the Department of Oncology, Hematology, and Bone Marrow Transplantation, Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg (P. Schafhausen), and Elblandklinikum Riesa, Riesa (J.S.) - all in Germany; King's College Hospital NHS Foundation Trust (A.G.K., S.G., R.T.), the National Institute for Health and Care Research and Wellcome King's Clinical Research Facility (A.G.K.), King's College London (A.G.K.), and Novartis Pharmaceuticals (C.T.), London, and St. James's University Hospital, Leeds (M.G., R.J.K.) - all in the United Kingdom; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing (B. Han, C.Y.), the Department of Hematology, Tianjin Medical University General Hospital (R.F., H.L.), and the Department of Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (L.Z.), Tianjin, and China Novartis Institutes for BioMedical Research, Shanghai (Z.W., S.L.) - all in China; the Division of Hematology, Hospital A Beneficência Portuguesa, São Paulo (P. Scheinberg), and ABC Medical School, Santo André (V.A.Q.M.) - both in Brazil; the Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland (J.P.M.); Osaka University Graduate School of Medicine, Suita (Y.U.), Kyoto University Hospital, Kyoto (T.K.), and Japanese Red Cross Society Suwa Hospital, Suwa (M.U.) - all in Japan; Duke University School of Medicine and Duke Cancer Institute, Durham, NC (C.M.C.); Unità Operativa Complessa Oncoematologia, AULSS7 Pedemontana, Bassano del Grappa (E.D.B.), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan (W.B.), Division of Hematology, University of Turin, Città della Salute e della Scienza, Turin (E.B.), Instituto per lo Studio, la Prevenzione e la Rete Oncologica, and Azienda Ospedaliero-Universitaria Careggi, Florence (R.N.), AORN Moscati, Avellino (L.M., A.M.R.), and University of Naples Federico II, Naples (A.M.R.) - all in Italy; Radboud University Medical Center, Nijmegen, the Netherlands (S.M.C.L.); the Hematology Unit, Department of Medicine, Hospital Umum Sarawak, Kuching (L.P.C.), and the Hematology Unit, Queen Elizabeth Hospital, Kota Kinabalu (L.W.L.L.) - both in Malaysia; Hospital Clinic of Barcelona (A.G.) and the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (R.P.L., A.G.K., M.G., W.B., S.T., L.T., F.S.F., L.M., A.M.R.) - both in Barcelona; the Department of Hematology and Oncology and the Department of Clinical Pathology, Hualien Tzu Chi Hospital, the Buddhist Tzu Chi Medical Foundation, and the Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan (W.-H.H.); the Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (J.H.J.); Medical College of Georgia, Augusta (A.K.); City of Hope Medical Center, Duarte, CA (V.P.); the Department of Laboratory Medicine, National University Hospital, Singapore (E.-S.Y.); Novartis Pharma (C.K., R.L., M.D.) and Novartis BioMedical Research (A.V.) - both in Basel, Switzerland; and Novartis Healthcare Private, Hyderabad, India (P.B., R.K., S.M.)." } }, { "@type": "Person", "name": "Robert A Brodsky", "url": "https://questionsmedicales.fr/author/Robert%20A%20Brodsky", "affiliation": { "@type": "Organization", "name": "Division of Hematology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD." } }, { "@type": "Person", "name": "Jun-Ichi Nishimura", "url": "https://questionsmedicales.fr/author/Jun-Ichi%20Nishimura", "affiliation": { "@type": "Organization", "name": "Osaka University Graduate School of Medicine, Department of Hematology and Oncology." } }, { "@type": "Person", "name": "Britta Höchsmann", "url": "https://questionsmedicales.fr/author/Britta%20H%C3%B6chsmann", "affiliation": { "@type": "Organization", "name": "Institute of Transfusion Medicine, University of Ulm, Ulm, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Using Synthetic Biology to Understand the Function of Plant Specialized Metabolites.", "datePublished": "2024-02-29", "url": "https://questionsmedicales.fr/article/38424065", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1146/annurev-arplant-060223-013842" } }, { "@type": "ScholarlyArticle", "name": "Measurement of Functional Brain Network Connectivity in People with Orthostatic Tremor.", "datePublished": "2024-02-27", "url": "https://questionsmedicales.fr/article/38539608", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/brainsci14030219" } }, { "@type": "ScholarlyArticle", "name": "Recovery of functional independence following major burn: A systematic review.", "datePublished": "2024-02-27", "url": "https://questionsmedicales.fr/article/38492981", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.burns.2024.02.017" } }, { "@type": "ScholarlyArticle", "name": "A potential function for MicroRNA-124 in normal and pathological bone conditions.", "datePublished": "2024-02-27", "url": "https://questionsmedicales.fr/article/38577015", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ncrna.2024.02.018" } }, { "@type": "ScholarlyArticle", "name": "Modulation of PDI Functions by Localization: The Example of the Anterior Gradient Family.", "datePublished": "2024-02-27", "url": "https://questionsmedicales.fr/article/38411504", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1089/ars.2024.0561" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations urologiques", "item": "https://questionsmedicales.fr/mesh/D020924" }, { "@type": "ListItem", "position": 5, "name": "Protéinurie", "item": "https://questionsmedicales.fr/mesh/D011507" }, { "@type": "ListItem", "position": 6, "name": "Hémoglobinurie", "item": "https://questionsmedicales.fr/mesh/D006456" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hémoglobinurie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hémoglobinurie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hémoglobinurie", "description": "Comment diagnostiquer l'hémoglobinurie ?\nQuels tests sont utilisés pour confirmer l'hémoglobinurie ?\nQuels signes indiquent une hémoglobinurie ?\nL'hémoglobinurie est-elle visible à l'œil nu ?\nQuels autres tests peuvent être nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D006456?mesh_terms=Likelihood+Functions&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hémoglobinurie", "description": "Quels sont les symptômes de l'hémoglobinurie ?\nL'hémoglobinurie cause-t-elle des douleurs ?\nPeut-on avoir de la fièvre avec l'hémoglobinurie ?\nL'hémoglobinurie entraîne-t-elle une anémie ?\nY a-t-il des signes urinaires associés ?", "url": "https://questionsmedicales.fr/mesh/D006456?mesh_terms=Likelihood+Functions&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hémoglobinurie", "description": "Comment prévenir l'hémoglobinurie ?\nLes infections urinaires peuvent-elles être évitées ?\nY a-t-il des mesures spécifiques pour les athlètes ?\nLes maladies héréditaires peuvent-elles être évitées ?\nL'alimentation joue-t-elle un rôle ?", "url": "https://questionsmedicales.fr/mesh/D006456?mesh_terms=Likelihood+Functions&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hémoglobinurie", "description": "Comment traiter l'hémoglobinurie ?\nLes transfusions sont-elles nécessaires ?\nDes médicaments peuvent-ils aider ?\nL'hydratation est-elle importante ?\nQuand consulter un médecin pour l'hémoglobinurie ?", "url": "https://questionsmedicales.fr/mesh/D006456?mesh_terms=Likelihood+Functions&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hémoglobinurie", "description": "Quelles complications peuvent survenir ?\nL'hémoglobinurie peut-elle endommager les reins ?\nY a-t-il un risque d'infection ?\nDes problèmes cardiovasculaires peuvent-ils survenir ?\nL'hémoglobinurie peut-elle être fatale ?", "url": "https://questionsmedicales.fr/mesh/D006456?mesh_terms=Likelihood+Functions&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hémoglobinurie", "description": "Quels sont les facteurs de risque de l'hémoglobinurie ?\nLes athlètes sont-ils plus à risque ?\nLes maladies génétiques augmentent-elles le risque ?\nCertains médicaments sont-ils des facteurs de risque ?\nL'âge influence-t-il le risque d'hémoglobinurie ?", "url": "https://questionsmedicales.fr/mesh/D006456?mesh_terms=Likelihood+Functions&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hémoglobinurie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test urinaire détecte l'hémoglobine libre, souvent accompagné d'analyses sanguines." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer l'hémoglobinurie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de laboratoire comme l'analyse d'urine et la numération des globules rouges sont utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une hémoglobinurie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une urine de couleur rouge ou brune, associée à des douleurs abdominales, peut indiquer l'hémoglobinurie." } }, { "@type": "Question", "name": "L'hémoglobinurie est-elle visible à l'œil nu ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'urine peut apparaître rougeâtre ou brunâtre, mais des tests sont nécessaires pour confirmation." } }, { "@type": "Question", "name": "Quels autres tests peuvent être nécessaires ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests pour évaluer la fonction rénale et rechercher des infections peuvent être requis." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hémoglobinurie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent urine colorée, douleurs abdominales et fatigue, selon la cause." } }, { "@type": "Question", "name": "L'hémoglobinurie cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs abdominales ou lombaires peuvent accompagner l'hémoglobinurie." } }, { "@type": "Question", "name": "Peut-on avoir de la fièvre avec l'hémoglobinurie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une fièvre peut survenir si l'hémoglobinurie est causée par une infection sous-jacente." } }, { "@type": "Question", "name": "L'hémoglobinurie entraîne-t-elle une anémie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la destruction des globules rouges peut provoquer une anémie, entraînant fatigue et faiblesse." } }, { "@type": "Question", "name": "Y a-t-il des signes urinaires associés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des mictions fréquentes ou douloureuses peuvent être présents avec l'hémoglobinurie." } }, { "@type": "Question", "name": "Comment prévenir l'hémoglobinurie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les traumatismes, les infections et maintenez une bonne hydratation pour prévenir l'hémoglobinurie." } }, { "@type": "Question", "name": "Les infections urinaires peuvent-elles être évitées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hygiène et une hydratation adéquate aident à prévenir les infections urinaires." } }, { "@type": "Question", "name": "Y a-t-il des mesures spécifiques pour les athlètes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les athlètes doivent éviter les blessures et bien s'hydrater pour prévenir l'hémoglobinurie." } }, { "@type": "Question", "name": "Les maladies héréditaires peuvent-elles être évitées ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, mais un suivi médical régulier peut aider à gérer les risques associés aux maladies héréditaires." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut renforcer le système immunitaire et réduire les risques d'infections." } }, { "@type": "Question", "name": "Comment traiter l'hémoglobinurie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la cause sous-jacente, incluant transfusions ou médicaments." } }, { "@type": "Question", "name": "Les transfusions sont-elles nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des transfusions peuvent être nécessaires si l'hémoglobinurie cause une anémie sévère." } }, { "@type": "Question", "name": "Des médicaments peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments pour traiter l'infection ou la maladie sous-jacente peuvent être prescrits." } }, { "@type": "Question", "name": "L'hydratation est-elle importante ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hydratation aide à diluer l'urine et à réduire les symptômes de l'hémoglobinurie." } }, { "@type": "Question", "name": "Quand consulter un médecin pour l'hémoglobinurie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un médecin si vous avez une urine colorée ou des symptômes associés persistants." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent l'anémie sévère, des lésions rénales et des infections urinaires." } }, { "@type": "Question", "name": "L'hémoglobinurie peut-elle endommager les reins ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une hémoglobinurie prolongée peut entraîner des lésions rénales et une insuffisance rénale." } }, { "@type": "Question", "name": "Y a-t-il un risque d'infection ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hémoglobinurie peut augmenter le risque d'infections urinaires et rénales." } }, { "@type": "Question", "name": "Des problèmes cardiovasculaires peuvent-ils survenir ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une anémie sévère due à l'hémoglobinurie peut entraîner des problèmes cardiovasculaires." } }, { "@type": "Question", "name": "L'hémoglobinurie peut-elle être fatale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Dans de rares cas, des complications graves peuvent survenir, rendant la situation potentiellement fatale." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de l'hémoglobinurie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les traumatismes, infections, maladies héréditaires et certains médicaments augmentent le risque." } }, { "@type": "Question", "name": "Les athlètes sont-ils plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les athlètes peuvent être à risque en raison de traumatismes répétés et de déshydratation." } }, { "@type": "Question", "name": "Les maladies génétiques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la drépanocytose augmentent le risque d'hémoglobinurie." } }, { "@type": "Question", "name": "Certains médicaments sont-ils des facteurs de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments comme les antibiotiques peuvent provoquer une hémoglobinurie." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'hémoglobinurie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus à risque en raison de maladies sous-jacentes." } } ] } ] }

Sources (10000 au total)

Recovery of functional independence following major burn: A systematic review.

Major burn injury, despite advancements in care and prevention, can have a profound impact on long-term morbidity, affecting quality of life and socioeconomic standing. We aim to explore factors predi... A systematic search of four databases (MEDLINE, EMBASE, COCHRANE, CINAHL) was conducted for studies reporting outcomes pertaining to physical ability indicative of independent function in adult (>15 y... 21 eligible studies were included comprising 1298 major burns survivors with a combined mean age of 39.6 y and a mean TBSA of 25.8%. The most significant recurring factors impacting recovery of indepe... Major burn survivors have protracted recovery with potential for persistent chronic impairments, remaining consistently below baseline levels of function. Non-modifiable factors such as age and gender...

Modulation of PDI Functions by Localization: The Example of the Anterior Gradient Family.

Oxidative folding within the endoplasmic reticulum (ER) introduces disulfide bonds into nascent polypeptides, ensuring proteins' stability and proper functioning. Consequently, this process is critica... Over the years, there have been increasing reports of the (re)localization of PDI family members and other ER-localized proteins to various compartments. A prime example is the Anterior gradient (AGR)... Here, we summarize the functions of PDIs and their gain or loss of functions in non-ER locations. We will focus on the activity, localization, and function of the AGR proteins: AGR1, AGR2, and AGR3.... Targeting PDIs in general and AGRs in particular is a promising strategy in different human diseases. Thus, there is a need for innovative strategies and tools aimed at targeting PDIs; those strategie...

Cystatin C should be routinely available for estimating kidney function.

In this report, we summarize why the availability of cystatin C is important across a variety of clinical scenarios, the recent literature on when, why and in whom cystatin C testing should be conside... Large intra-individual discrepancies between estimated glomerular filtration rate by creatinine (eGFRcr) and estimated glomerular filtration rate by creatinine eGFRcys (known as eGFRdiff) are observed... Cystatin C improves sensitivity and specificity of chronic kidney disease diagnosis, improves detection of harmful acute and chronic changes in kidney function, improves precision of treatment eligibi...

Functional analysis: what have we learned in 85 years?

Even though the term "functional analysis" (FA) is prevalent in the current behavioral literature, the concept and process have roots in the early days of basic research in behavior analysis. Furtherm... FA is considered a gold standard of functional assessment. However, several arguments about limitations relating to methodological issues in FA and its ecological validity have been put forward. Some ... The literature on the subject clearly shows that refinements have been aimed not only at improving some of the methodological characteristics of FA but also at adapting the strategy for real-world app...